These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32557826)

  • 1. Application of therapeutic plasma exchange in dogs with immune-mediated thrombocytopenia.
    Kopecny L; Palm CA; Naylor S; Kirby J; Cowgill LD
    J Vet Intern Med; 2020 Jul; 34(4):1576-1581. PubMed ID: 32557826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003).
    Putsche JC; Kohn B
    J Am Anim Hosp Assoc; 2008; 44(5):250-7. PubMed ID: 18762561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of membrane-based therapeutic plasma exchange as adjunctive treatment for immune-mediated hematologic disorders in dogs.
    Francey T; Etter M; Schweighauser A
    J Vet Intern Med; 2021 Mar; 35(2):925-935. PubMed ID: 33571376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of vincristine-loaded platelet therapy in three dogs with refractory immune-mediated thrombocytopenia.
    Park HJ; Kim JW; Song KH; Seo KW
    J Vet Sci; 2015; 16(1):127-30. PubMed ID: 25269722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic plasma exchange as adjunct therapy in 3 dogs with myasthenia gravis and myasthenia-like syndrome.
    Vitalo A; Buckley G; Londoño L
    J Vet Emerg Crit Care (San Antonio); 2021 Jan; 31(1):106-111. PubMed ID: 33217167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2009; 23(5):1071-8. PubMed ID: 19674280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet volume and plateletcrit in dogs with presumed primary immune-mediated thrombocytopenia.
    Schwartz D; Sharkey L; Armstrong PJ; Knudson C; Kelley J
    J Vet Intern Med; 2014; 28(5):1575-9. PubMed ID: 25056453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine pemphigus foliaceus with concurrent immune-mediated thrombocytopenia.
    Kawarai S; Hisasue M; Matsuura S; Ito T; Inoue Y; Neo S; Fujii Y; Madarame H; Shirota K; Tsuchiya R
    J Am Anim Hosp Assoc; 2015; 51(1):56-63. PubMed ID: 25415212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and predictors of outcome in dogs with immune-mediated thrombocytopenia.
    O'Marra SK; Delaforcade AM; Shaw SP
    J Am Vet Med Assoc; 2011 Feb; 238(3):346-52. PubMed ID: 21281218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory and immunosuppressive drug protocols in the treatment of canine primary immune thrombocytopenia, a scoping review.
    Kristiansen PS; Nielsen LN
    Acta Vet Scand; 2021 Dec; 63(1):54. PubMed ID: 34961516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of therapeutic plasma exchange on serum immunoglobulin concentrations in a dog with refractory immune-mediated hemolytic anemia.
    Scagnelli AM; Walton SA; Liu CC; Acierno MJ
    J Am Vet Med Assoc; 2018 May; 252(9):1108-1112. PubMed ID: 29641335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrifugal therapeutic plasma exchange in dogs with immune-mediated hemolytic anemia (2016-2018): 7 cases.
    Culler CA; Vigani A; Ripoll AZ; Gareau A; Suter SE
    J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):645-652. PubMed ID: 35499963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of primary immune-mediated thrombocytopenia in dogs.
    Simpson K; Chapman P; Klag A
    J Small Anim Pract; 2018 Nov; 59(11):674-680. PubMed ID: 30102418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating hypercoagulability during treatment for immune-mediated thrombocytopenia: a pilot study.
    O'Marra SK; Shaw SP; deLaforcade AM
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):126-30. PubMed ID: 22316313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of acute bilirubin encephalopathy in a dog with immune-mediated hemolytic anemia using therapeutic plasma exchange.
    Heffner GG; Cavanagh A; Nolan B
    J Vet Emerg Crit Care (San Antonio); 2019 Sep; 29(5):549-557. PubMed ID: 31423707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazole orange-positive platelets in a dog with idiopathic thrombocytopenic purpura.
    Hanahachi A; Kano R; Watari T; Hasegawa A
    Vet Rec; 2002 Jan; 150(2):48-9. PubMed ID: 11829069
    [No Abstract]   [Full Text] [Related]  

  • 18. ACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats.
    LeVine DN; Goggs R; Kohn B; Mackin AJ; Kidd L; Garden OA; Brooks MB; Eldermire ERB; Abrams-Ogg A; Appleman EH; Archer TM; Bianco D; Blois SL; Brainard BM; Callan MB; Fellman CL; Haines JM; Hale AS; Huang AA; Lucy JM; O'Marra SK; Rozanski EA; Thomason JM; Walton JE; Wilson HE
    J Vet Intern Med; 2024; 38(4):1982-2007. PubMed ID: 38779941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presumptive immune-mediated thrombocytopenia secondary to massive Africanized bee envenomation in a dog.
    Nakamura RK; Fenty RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2013; 23(6):652-6. PubMed ID: 24304842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful management of clinical signs associated with hepatic encephalopathy with manual therapeutic plasma exchange in a dog.
    Culler CA; Reinhardt A; Vigani A
    J Vet Emerg Crit Care (San Antonio); 2020 May; 30(3):312-317. PubMed ID: 32077185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.